Pillstats
Rx only · Suspension · Oral

Clobazam

Brands: Onfi · Clobazam

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)21241
US makers11 labelers
Packages11
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.496$0.993$1.49$1.99Dec 2025Apr 2026Jul 2026
$1.695
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
11
Active US suppliers
18%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

28K57K85K113K2025 Q12025 Q22025 Q32025 Q42026 Q1
99K
Rx · 2026 Q1
24.1M
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager1SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Chartwell RX, LLCunknown1SUPPLYING
Lundbeck Pharmaceuticals LLCunknown1SUPPLYING
Ascend Laboratories, LLCunknown1SUPPLYING
Precision Dose, Inc.unknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jul 16, 2019
    RECALLRecall (Class II): Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road, Princ…

    Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed. — Recalling firm: Bionpharma Inc. — Nationwide in the USA